DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/kdn97l/osteoporosis) has announced the addition of the "Osteoporosis Global Clinical Trials Review, H2, 2013" report to their offering.
The clinical trial report, Osteoporosis Global Clinical Trials Review, H2, 2013" provides data on the Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Osteoporosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Osteoporosis.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Companies Mentioned:
- Amgen Inc.
- AstraZeneca PLC
- Chiesi Farmaceutici SpA
- Chugai Pharmaceutical Co., Ltd.
- Clinical Trial Overview of Novartis AG
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Ligand Pharmaceuticals, Inc.
- NPS Pharmaceuticals, Inc.
- Novartis AG
- Ono Pharmaceutical Co., Ltd.
- Radius Health, Inc.
- Sanofi
- Takeda GmbH
- Warner Chilcott Plc
For more information visit http://www.researchandmarkets.com/research/kdn97l/osteoporosis
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
